Does TISLELIZUMAB Cause Myocarditis? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Myocarditis have been filed in association with TISLELIZUMAB (TEVIMBRA). This represents 0.8% of all adverse event reports for TISLELIZUMAB.
38
Reports of Myocarditis with TISLELIZUMAB
0.8%
of all TISLELIZUMAB reports
6
Deaths
17
Hospitalizations
How Dangerous Is Myocarditis From TISLELIZUMAB?
Of the 38 reports, 6 (15.8%) resulted in death, 17 (44.7%) required hospitalization, and 8 (21.1%) were considered life-threatening.
Is Myocarditis Listed in the Official Label?
Yes, Myocarditis is listed as a known adverse reaction in the official FDA drug label for TISLELIZUMAB.
What Other Side Effects Does TISLELIZUMAB Cause?
Myelosuppression (2,142)
White blood cell count decreased (327)
Neutrophil count decreased (277)
Hepatic function abnormal (221)
Pruritus (213)
Rash (208)
Platelet count decreased (183)
Pyrexia (175)
Nausea (165)
Diarrhoea (145)
What Other Drugs Cause Myocarditis?
CLOZAPINE (1,702)
PEMBROLIZUMAB (1,060)
NIVOLUMAB (959)
IPILIMUMAB (475)
OLANZAPINE (425)
ATEZOLIZUMAB (372)
CARBOPLATIN (325)
QUETIAPINE (315)
MESALAMINE (272)
BEVACIZUMAB (230)
Which TISLELIZUMAB Alternatives Have Lower Myocarditis Risk?
TISLELIZUMAB vs TISOTUMAB VEDOTIN
TISLELIZUMAB vs TISOTUMAB VEDOTIN-TFTV
TISLELIZUMAB vs TITANIUM DIOXIDE\ZINC
TISLELIZUMAB vs TIVICAY
TISLELIZUMAB vs TIVOZANIB